Timothy Armour – Chairman of the Press- Shy Investment Group

Timothy K. Armour commonly known as Tim is currently the sole Director at Janus Capital Group, and at the same time the Independent Chairman at AQR Funds. Tim has dedicated his whole career to Capital Group. Having earned a bachelor degree in economics from Middlebury College and a master’s degree from Columbia University, he got accepted into the Capital Group associates program and his career commenced almost immediately.

He initially worked as an Equity investment analyst where he trained to become Capital Group’s Management committee chairman. Tim is also a member of the board of directors at Janus Capital Group. Prior to being the director at Janus Capital Group, he was managing director at Morningstar and the president of mutual Funds Division and read full article.

Tim Armour came up with a certain reasoning that investors should “find active managers who earn their keep”. He is convinced that many financial managers have become indolent, and dependent on index funds and not researching companies. He adds that, index funds are not capable of making a difference on business trends..This can only be achieved by a firm financial manager capable of catching these trends.

After this, he was quick to make some really bold moves after getting appointed Chairman of Janus Capital Group. One of which includes the partnership with Samsung involving Asset Management. The deal entails both Capital Group and Samsung Asset Management working together to co-develop retirement resolutions and asset allocation products. Tim believes the greater plan is to co-design investment solutions to meet retirement needs of Korean investors and learn more about Tim.

The unexpected election victory of Donald Trump in November sparked dramatic changes in asset prices. Tim says that the recent change is profound and his guess is that they’ve hit the bottom this time round and Tim’s lacrosse camp.

Thor Halvorssen, Human Rights Foundation organizer, Not Looking for Recognition

Human rights activist Thor Halvorssen sat in the upper areas of the Christiana Theater in Oslo, Norway, listening in on a phone call. He was Chen Guangcheng and his wife, Yuan Weijing. Guangcheng was exiled Chinese dissident. He had been arrested following a peaceful demonstration against financial crimes committed against himself, his family, and others.

Guangcheng was talking about actor Christian Bale, who accompanied CNN reporters on a trip to China several years before. The actor and the camera crew went to beg the government’s forgiveness and barter for Guangcheng ‘s release. Bale and the CNN crew were harassed, assaulted, and stalked as they fled the area.

Mr Halvorssen is the founder of the Human Rights Foundation, an organization that works to educate about international human rights. The organization meets annually at the Oslo Freedom Forum where people share their stories and work together to find solutions to the world’s humanitarian crisis.

Halvorssen was never a stranger to the world’s humanitarian crisis. He was born in Venezuela and is of Norwegian and Venezuelan descent. Halvorssen’s father was arrested in the early 1990s. He was held for 70 days, beaten, and tortured. He was later found not guilty on charges of money laundering and terrorism. Halvorssen’s mother was also an activist. She attended the 2004 Venezuelan recall referendum where she was shot by government security agents. She survived. Click here to watch video.

Halvorssen’s passion and energy have been noted by his colleagues.

“I tell people that he is a force of nature,” said Berlin-based journalist Jamie Kirchick.

“He is very driven and energetic,” said Jacob Mchangama, a German activist. “His foundation has helped me to accomplish things that I could not have done on my own.”

Despite his high energy levels and good nature, Halvorssen has stated that he has no interest in being the face for the cause.

“I hate the idea of being the face of the organization,” Halvorssen said. “I like the idea of people focusing on the problem at hand, not the idea of ‘The Thor Show.'”

https://www.crunchbase.com/person/thor-halvorssen#/entity

Insights into Clay Siegal and His Seattle Genetics

Dr. Clay Siegal, a scientist by training has built Seattle Genetics on a scientific innovation foundation and rigorous research. He has steered capital-raising activities at Seattle Genetics securing over $1.2 billion through private and public financings as well as the initial public offering of the Company in 2001.

Genesis of Seattle Genetics

The primary goal of Seattle Genetics is helping patients. According to Siegal, he became aware of the limitation of tools available to oncologists as he watched his father’s cancer progression from when he was 19 to his death (while Siegal was 24). That built in him a desire towards improving those tools. After earning his George Washington University doctorate in genetics, Siegal spent some years at Pharmaceutical Research Institute of Bristol-Myers Squibb, which eventually brought him to Seattle.

His Motivations

Siegal’s goal is the treatment of patients suffering from cancer, and to perform better than is being currently done in terms of targeted drugs. He looks forward to each new day knowing that he is contributing something positive towards that goal.

His Winning Business Strategy

A key element of the business strategy adopted at Seattle Genetics is collaborating with several other innovators and industry leaders in the development of oncology drugs. These collaborations have effectively extended Seattle Genetics’ reach in terms of technology, allowing the Company to direct resources into new approaches and ideas.

Tips for Others

According to Clay Siegal, when in the 20s, most people think they know everything there is to know. When in the 30s, you sort of begin to realize they actually don’t. He says that now when he is over 40, he appreciates the fact that he doesn’t know much. His tip for others is to keep on learning as much they can, and to interact with people who are very smart.

About Clay Siegal

Dr. Siegall is the CEO/President and Board of Directors Chairman of Seattle Genetics, a company he co-founded in 1998. Before co-founding Seattle Genetics, he worked with the Pharmaceutical Research Institute of Bristol-Myers Squibb (between 1991 and 1997) and the National Institutes of Health’s National Cancer Institute (between 1988 and 1991). Dr. Clay Siegal has B.S. in Zoology from University of Maryland and a Ph.D. in Genetics from George Washington University.